The global Portable Transcutaneous Bilirubinometer market size is predicted to grow from US$ 103 million in 2025 to US$ 111 million in 2032; it is expected to grow at a CAGR of 1.4% from 2026 to 2032.

The core drivers of the development of the Portable Transcutaneous Bilirubinometer industry are twofold. First, the high incidence of neonatal jaundice creates a rigid clinical demand. The prevalence of jaundice in full-term and premature infants makes non-invasive and rapid testing equipment a necessity for neonatal health protection. Second, policy-driven improvements in the neonatal disease screening capabilities of primary healthcare systems, with relevant regulations listing transcutaneous bilirubin testing as a recommended method, coupled with the popularization and upgrading of equipment in primary healthcare institutions, continue to release market demand.

In 2024, global Portable Transcutaneous Bilirubinometers reached approximately 55,813 Units, with an average global market price of around 1,918.0 USD per Unit.

Portable Transcutaneous Bilirubinometers are non-invasive medical devices used to measure the level of bilirubin in a patients skin, primarily in neonates, to assess the risk of jaundice. These meters work by using light to estimate the bilirubin concentration in the subcutaneous tissue, which can be an indicator of the livers ability to process bilirubin.

Transcutaneous bilirubin measurement is performed by placing a sensor on the babys skin, usually on the forehead or chest, where the skin is thin. The device emits light at specific wavelengths, and based on the amount of light that is absorbed or reflected by the skin, the device calculates the bilirubin level. This method provides a quick, painless alternative to serum bilirubin tests, reducing the need for blood draws.

The upstream core components of Portable Transcutaneous Bilirubinometers mainly include light sources, photoelectric sensors, filters, microprocessors, etc. Typical suppliers include Hamamatsu Photonics, Nichia, Edmund Optics, Thorlabs, etc. The downstream applications are mainly in hospitals, clinics, community service centers, and postpartum care centers.

The single-line production capacity of Portable Transcutaneous Bilirubinometers varies significantly depending on the manufacturers scale, product positioning, and production model. Typically, the single-line production capacity of regular products is over 2,000 units, and the industry gross profit margin is in the range of 40%-60%.

Portable Transcutaneous Bilirubinometers are non-invasive sentinels protecting newborn health. Designed specifically for neonatal jaundice screening, these medical devices utilize spectral absorption technology. Simply place the probe lightly against the infants forehead or sternum, and within seconds, the difference in reflection between blue and green light is used to calculate bilirubin levels, completely eliminating the pain and waiting associated with traditional blood tests. From bedside screening in maternity wards to routine monitoring in primary care hospitals and home follow-up, this device, with its non-invasive, rapid, and safe characteristics, has become a key tool for the early detection and intervention of neonatal hyperbilirubinemia, building the first line of defense for the health of millions of newborns worldwide.

The global market for Portable Transcutaneous Bilirubinometers exhibits a distinct regional development pattern. North America, relying on its mature neonatal healthcare system and high medical investment, has stable and concentrated market demand. Local companies have accumulated deep expertise in device intelligence and clinical adaptability, occupying a core position in the global market. Europe excels in technological precision, with stringent medical standards driving equipment upgrades towards low-interference, high-precision solutions. Products not only serve the well-developed local healthcare network but also radiate globally through technology exports. The Asia-Pacific region has become the core engine of industry growth. China, with its large newborn population and policies promoting the widespread availability of basic medical equipment, has propelled domestic brands from followers to leaders. Meanwhile, emerging markets such as India and Southeast Asia, with their improving healthcare infrastructure, are releasing strong incremental demand. According to our data, in 2024, Asia held nearly 50% of the market share for Portable Transcutaneous Bilirubinometers, followed by Europe and North America. During the forecast period, emerging markets such as India and Southeast Asia are leading the global growth rate.

From a manufacturer perspective, globally, key manufacturers of Portable Transcutaneous Bilirubinometers include Drger, Mennen Medical, Philips, Konica Minolta, Beijing Maibang Optoelectronics, Ningbo Davy Medical, Weicai, AVI Healthcare, NEORUBIN (RECOVE GROUP), Nanjing Daofen Electronics, Likang Biotechnology, Boke Biotechnology, and Micro Lab. According to our data, the top 5 manufacturers accounted for over 70% of the global market share in 2024.

The convergence of multiple demands and policies has injected continuous growth momentum into the Portable Transcutaneous Bilirubinometers industry. The high incidence of neonatal jaundice forms a rigid demand foundation, while the monitoring needs of premature and high-risk infants further make the equipment a clinical necessity. At the policy level, countries are incorporating neonatal disease screening into their public health systems, while technological innovation is reshaping product value. Multi-wavelength spectral technology overcomes the bottleneck of skin color interference, and intelligent algorithms enable real-time data transmission and trend prediction, upgrading the equipment from a simple testing tool to an entry point for neonatal health management. Meanwhile, the publics growing preference for non-invasive medical care and increased awareness of home health monitoring have further broadened application scenarios, extending from hospitals to homes and forming a full-cycle monitoring ecosystem.

Infinity Market Research newest research report, the Portable Transcutaneous Bilirubinometer Industry Forecast looks at past sales and reviews total world Portable Transcutaneous Bilirubinometer sales in 2025, providing a comprehensive analysis by region and market sector of projected Portable Transcutaneous Bilirubinometer sales for 2026 through 2032. With Portable Transcutaneous Bilirubinometer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Portable Transcutaneous Bilirubinometer industry.

This Insight Report provides a comprehensive analysis of the global Portable Transcutaneous Bilirubinometer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Portable Transcutaneous Bilirubinometer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Portable Transcutaneous Bilirubinometer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Portable Transcutaneous Bilirubinometer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Portable Transcutaneous Bilirubinometer.

This report presents a comprehensive overview, market shares, and growth opportunities of Portable Transcutaneous Bilirubinometer market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Standard Type
    Intelligent Type
    Segmentation by Power Supply Method:
    Rechargeable Type
    Non-rechargeable Type
    Segmentation by Technology:
    Single Measurement Optical Path
    Dual Measurement Optical Path

Segmentation by Application:

    Hospitals
    Clinics
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Drger
    Mennen Medical
    Philips
    Konica Minolta
    Beijing M&B Electronic Instruments
    Ningbo David Medical Device
    VECH MEDICAL
    AVI Healthcare
    NEORUBIN (RECOVE GROUP)
    Dolphin Nanjing electronics
    Heal Force
    BIOBASE GROUP
    Micro Lab

Key Questions Addressed in this Report

What is the 10-year outlook for the global Portable Transcutaneous Bilirubinometer market?
What factors are driving Portable Transcutaneous Bilirubinometer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Portable Transcutaneous Bilirubinometer market opportunities vary by end market size?
How does Portable Transcutaneous Bilirubinometer break out by Type, by Application?